CFDE Data Portal | Search DYRK2

	Label	Description
	DYRK2 associations Collection (Entity type)	Associations for DYRK2_associations
	DYRK2 Up Gene Set (Entity type)	A Gene Set from LINCS
	DYRK2 Down Gene Set (Entity type)	A Gene Set from LINCS
	DYRK2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	DYRK2 Gene (Entity type)	ENSG00000127334 - dual specificity tyrosine phosphorylation regulated kinase 2
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

DYRK2 associations

Associations for DYRK2_associations

DYRK2 Up

A Gene Set from LINCS

DYRK2 Down

A Gene Set from LINCS

DYRK2 associations.tsv

A file from IDG as part of the Harmonizome project

DYRK2

ENSG00000127334 - dual specificity tyrosine phosphorylation regulated kinase 2

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE225869 1 V 0 TEMOZOLOMIDE HUMAN DN

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.